QUESTIONS

1. Identify three factors that are driving pharmaceutical companies to host clinical drug trials

overseas.

2. What regulations are in place to oversee the professional and ethical management of these trials?

3. If patients lack the language skills or education to understand the significance of informed

consent or the use of a placebo, is it ethical to allow them to participate in the drug trial? Why or

why not?

4. What proposals would you offer to make the offshoring of clinical drug trials a more ethical

process for all the stakeholders involved?